Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Phase I clinical trial of adoptive transfer of multi-virus-specific T cells into TCRaß+/CD19+-depleted haploidentical HSCT recipients
Protocol ID
P305
Disease (Sub Disease)
Haematological diseases
Diagnosis Stage
"New Diagnosis
Relapse/Refractory"
Relapse/Refractory"
Location
VIC
Sponsor
QIMR Berghofer Medical Research Institute
Links
Trial Status
Open
Sites
Queensland Children's Hospital
Royal Children's Hospital
Royal Children's Hospital
Study Type
Supportive Care
Phase
Phase 1
Age Eligibility
3 months to 18 years
ANZCTR
ACTRN12620000141943
| Study Title | Phase I clinical trial of adoptive transfer of multi-virus-specific T cells into TCRaß+/CD19+-depleted haploidentical HSCT recipients |
|---|---|
| Protocol ID | P305 |
| Disease (Sub Disease) | Haematological diseases |
| Diagnosis Stage | "New Diagnosis Relapse/Refractory" |
| Location | VIC |
| Sponsor | QIMR Berghofer Medical Research Institute/ |
| Links | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378935&isReview=true |
| Trial Status | Open |
| Trial Open Date | 17/06/2020 |
| Sites | Queensland Children's Hospital / Royal Children's Hospital |
| Study Type | Supportive Care |
| Phase | Phase 1 |
| Age Eligibility | 3 months to 18 years |
| ANZCTR | ACTRN12620000141943 |